Blackstone Life Sciences Yield L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Apr 29, 2022, it has sold $1,642,407,000 of interests to 11 investors since its first sale in Sep 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include BXLS Yield L.L.C; John Finley; Eric Liaw.
- Total raised
- $1,642,407,000Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Sep 17, 2021
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- BXLS Yield L.L.C; John Finley; Eric Liaw
- Latest Form D
- Apr 29, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Blackstone Life Sciences Yield L.P.
What is the minimum investment for Blackstone Life Sciences Yield L.P.?
Blackstone Life Sciences Yield L.P.'s latest Form D, filed Apr 29, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Blackstone Life Sciences Yield L.P.?
Blackstone Life Sciences Yield L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Blackstone Life Sciences Yield L.P. raised?
Blackstone Life Sciences Yield L.P. reports $1,642,407,000 sold from 11 investors on its Form D filed Apr 29, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is Blackstone Life Sciences Yield L.P. based?
Blackstone Life Sciences Yield L.P. is based in New York, New York.
When did Blackstone Life Sciences Yield L.P. launch?
Blackstone Life Sciences Yield L.P. reports its first sale in Sep 2021.
Size compared with every private equity fund
Raised more than 96% of the 3,668 private equity funds based in New York, and more than 96% of all 8,918 that report sales.
Other funds with the same team
- Blackstone Capital Partners IX L.P.$20B
- Blackstone Capital Partners IX (LUX) SCSp$20B
- Blackstone Capital Partners Asia III - B L.P.$10B
- Blackstone Capital Partners Asia III - BL L.P.$10B
- BCP Asia III Feeder L.P.$8.0B
- Blackstone Life Sciences VI - B L.P.$6.3B
- Blackstone Growth II - BL L.P.$4.5B
- Blackstone Infrastructure Partners Europe F (CYM) L.P.$1.3B